Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of fibrin adhesive to reduce esophagojejunal anastomotic dehiscence in total gastrectomy
2018-001778-12Phase 3Active
- Sponsor
- Germans Trias i Pujol Research Institute
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of tisseel in gastric adenocarcinoma and Esophagojejunal anastomotic dehiscence (EJAD) (2 arms), sponsored by Germans Trias i Pujol Research Institute. Started May 2019; status: active.
02
Drugs
tisseel
03
Conditions
gastric adenocarcinomaEsophagojejunal anastomotic dehiscence (EJAD)
Beyond the preview
Go deeper on 2018-001778-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001778-12.